APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Carfilzomib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Carfilzomib Market Analysis and Forecast 2026-2032

Report ID 173975210223 December 2025197 pages

Choose your research edition.

Industry ResearchCarfilzomib Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Carfilzomib Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Carfilzomib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carfilzomib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Carfilzomib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Carfilzomib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Carfilzomib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Carfilzomib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Carfilzomib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Carfilzomib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Carfilzomib include Amgen, AstraZeneca and Natco, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Carfilzomib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Carfilzomib, also provides the sales of main regions and countries. Of the upcoming market potential for Carfilzomib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Carfilzomib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Carfilzomib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Carfilzomib sales, projected growth trends, production technology, application and end-user industry.

Carfilzomib Segment by Company

Amgen

AstraZeneca

Natco

Carfilzomib Segment by Type

10mg Injection

30mg Injection

60mg Injection

Carfilzomib Segment by Application

Drug Center

Hospital

Clinic

Others

Carfilzomib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carfilzomib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carfilzomib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carfilzomib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Carfilzomib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Carfilzomib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carfilzomib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Carfilzomib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Injection Major Manufacturers Table 3. 30mg Injection Major Manufacturers Table 4. 60mg Injection Major Manufacturers Table 5. Global Carfilzomib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Center Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Carfilzomib Industry Trends Table 11. Carfilzomib Industry Drivers Table 12. Carfilzomib Industry Opportunities and Challenges Table 13. Carfilzomib Industry Restraints Table 14. Global Carfilzomib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Carfilzomib Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Carfilzomib Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Carfilzomib Revenue Market Share by Region (2021-2026) Table 18. Global Carfilzomib Revenue Market Share by Region (2027-2032) Table 19. Global Carfilzomib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Carfilzomib Sales by Region (2021-2026) & (k units) Table 21. Global Carfilzomib Sales by Region (2027-2032) & (k units) Table 22. Global Carfilzomib Sales Market Share by Region (2021-2026) Table 23. Global Carfilzomib Sales Market Share by Region (2027-2032) Table 24. Global Carfilzomib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Carfilzomib Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Carfilzomib Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Carfilzomib Sales Market Share by Manufacturers (2021-2026) Table 28. Global Carfilzomib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Carfilzomib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Carfilzomib Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Carfilzomib Manufacturers, Product Type & Application Table 32. Global Carfilzomib Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Carfilzomib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Carfilzomib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Carfilzomib Revenue Market Share by Type (2021-2026) Table 39. Global Carfilzomib Revenue Market Share by Type (2027-2032) Table 40. Global Carfilzomib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Carfilzomib Sales by Type (2021-2026) & (k units) Table 42. Global Carfilzomib Sales by Type (2027-2032) & (k units) Table 43. Global Carfilzomib Sales Market Share by Type (2021-2026) Table 44. Global Carfilzomib Sales Market Share by Type (2027-2032) Table 45. Global Carfilzomib Price by Type (2021-2026) & (US$/unit) Table 46. Global Carfilzomib Price by Type (2027-2032) & (US$/unit) Table 47. Global Carfilzomib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Carfilzomib Revenue Market Share by Application (2021-2026) Table 51. Global Carfilzomib Revenue Market Share by Application (2027-2032) Table 52. Global Carfilzomib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Carfilzomib Sales by Application (2021-2026) & (k units) Table 54. Global Carfilzomib Sales by Application (2027-2032) & (k units) Table 55. Global Carfilzomib Sales Market Share by Application (2021-2026) Table 56. Global Carfilzomib Sales Market Share by Application (2027-2032) Table 57. Global Carfilzomib Price by Application (2021-2026) & (US$/unit) Table 58. Global Carfilzomib Price by Application (2027-2032) & (US$/unit) Table 59. Amgen Company Information Table 60. Amgen Business Overview Table 61. Amgen Carfilzomib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Amgen Carfilzomib Product Portfolio Table 63. Amgen Recent Development Table 64. AstraZeneca Company Information Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Carfilzomib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. AstraZeneca Carfilzomib Product Portfolio Table 68. AstraZeneca Recent Development Table 69. Natco Company Information Table 70. Natco Business Overview Table 71. Natco Carfilzomib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Natco Carfilzomib Product Portfolio Table 73. Natco Recent Development Table 74. North America Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Carfilzomib Sales by Type (2021-2026) & (k units) Table 77. North America Carfilzomib Sales by Type (2027-2032) & (k units) Table 78. North America Carfilzomib Sales Price by Type (2021-2026) & (US$/unit) Table 79. North America Carfilzomib Sales Price by Type (2027-2032) & (US$/unit) Table 80. North America Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Carfilzomib Sales by Application (2021-2026) & (k units) Table 83. North America Carfilzomib Sales by Application (2027-2032) & (k units) Table 84. North America Carfilzomib Sales Price by Application (2021-2026) & (US$/unit) Table 85. North America Carfilzomib Sales Price by Application (2027-2032) & (US$/unit) Table 86. North America Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Carfilzomib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Carfilzomib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Carfilzomib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 90. North America Carfilzomib Sales by Country (2021-2026) & (k units) Table 91. North America Carfilzomib Sales by Country (2027-2032) & (k units) Table 92. North America Carfilzomib Sales Price by Country (2021-2026) & (US$/unit) Table 93. North America Carfilzomib Sales Price by Country (2027-2032) & (US$/unit) Table 94. United States Carfilzomib Revenue (2021-2032) & (US$ Million) Table 95. Canada Carfilzomib Revenue (2021-2032) & (US$ Million) Table 96. Mexico Carfilzomib Revenue (2021-2032) & (US$ Million) Table 97. Europe Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Carfilzomib Sales by Type (2021-2026) & (k units) Table 100. Europe Carfilzomib Sales by Type (2027-2032) & (k units) Table 101. Europe Carfilzomib Sales Price by Type (2021-2026) & (US$/unit) Table 102. Europe Carfilzomib Sales Price by Type (2027-2032) & (US$/unit) Table 103. Europe Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Carfilzomib Sales by Application (2021-2026) & (k units) Table 106. Europe Carfilzomib Sales by Application (2027-2032) & (k units) Table 107. Europe Carfilzomib Sales Price by Application (2021-2026) & (US$/unit) Table 108. Europe Carfilzomib Sales Price by Application (2027-2032) & (US$/unit) Table 109. Europe Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Carfilzomib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Carfilzomib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Carfilzomib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 113. Europe Carfilzomib Sales by Country (2021-2026) & (k units) Table 114. Europe Carfilzomib Sales by Country (2027-2032) & (k units) Table 115. Europe Carfilzomib Sales Price by Country (2021-2026) & (US$/unit) Table 116. Europe Carfilzomib Sales Price by Country (2027-2032) & (US$/unit) Table 117. Germany Carfilzomib Revenue (2021-2032) & (US$ Million) Table 118. France Carfilzomib Revenue (2021-2032) & (US$ Million) Table 119. U.K. Carfilzomib Revenue (2021-2032) & (US$ Million) Table 120. Italy Carfilzomib Revenue (2021-2032) & (US$ Million) Table 121. Russia Carfilzomib Revenue (2021-2032) & (US$ Million) Table 122. Spain Carfilzomib Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Carfilzomib Revenue (2021-2032) & (US$ Million) Table 124. Switzerland Carfilzomib Revenue (2021-2032) & (US$ Million) Table 125. Sweden Carfilzomib Revenue (2021-2032) & (US$ Million) Table 126. Poland Carfilzomib Revenue (2021-2032) & (US$ Million) Table 127. China Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 128. China Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 129. China Carfilzomib Sales by Type (2021-2026) & (k units) Table 130. China Carfilzomib Sales by Type (2027-2032) & (k units) Table 131. China Carfilzomib Sales Price by Type (2021-2026) & (US$/unit) Table 132. China Carfilzomib Sales Price by Type (2027-2032) & (US$/unit) Table 133. China Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 134. China Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 135. China Carfilzomib Sales by Application (2021-2026) & (k units) Table 136. China Carfilzomib Sales by Application (2027-2032) & (k units) Table 137. China Carfilzomib Sales Price by Application (2021-2026) & (US$/unit) Table 138. China Carfilzomib Sales Price by Application (2027-2032) & (US$/unit) Table 139. Asia Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Carfilzomib Sales by Type (2021-2026) & (k units) Table 142. Asia Carfilzomib Sales by Type (2027-2032) & (k units) Table 143. Asia Carfilzomib Sales Price by Type (2021-2026) & (US$/unit) Table 144. Asia Carfilzomib Sales Price by Type (2027-2032) & (US$/unit) Table 145. Asia Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Carfilzomib Sales by Application (2021-2026) & (k units) Table 148. Asia Carfilzomib Sales by Application (2027-2032) & (k units) Table 149. Asia Carfilzomib Sales Price by Application (2021-2026) & (US$/unit) Table 150. Asia Carfilzomib Sales Price by Application (2027-2032) & (US$/unit) Table 151. Asia Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Carfilzomib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Carfilzomib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Carfilzomib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 155. Asia Carfilzomib Sales by Country (2021-2026) & (k units) Table 156. Asia Carfilzomib Sales by Country (2027-2032) & (k units) Table 157. Asia Carfilzomib Sales Price by Country (2021-2026) & (US$/unit) Table 158. Asia Carfilzomib Sales Price by Country (2027-2032) & (US$/unit) Table 159. Japan Carfilzomib Revenue (2021-2032) & (US$ Million) Table 160. South Korea Carfilzomib Revenue (2021-2032) & (US$ Million) Table 161. India Carfilzomib Revenue (2021-2032) & (US$ Million) Table 162. Australia Carfilzomib Revenue (2021-2032) & (US$ Million) Table 163. Taiwan Carfilzomib Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Carfilzomib Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Carfilzomib Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Carfilzomib Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Carfilzomib Sales by Type (2021-2026) & (k units) Table 168. SAMEA Carfilzomib Sales by Type (2027-2032) & (k units) Table 169. SAMEA Carfilzomib Sales Price by Type (2021-2026) & (US$/unit) Table 170. SAMEA Carfilzomib Sales Price by Type (2027-2032) & (US$/unit) Table 171. SAMEA Carfilzomib Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Carfilzomib Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Carfilzomib Sales by Application (2021-2026) & (k units) Table 174. SAMEA Carfilzomib Sales by Application (2027-2032) & (k units) Table 175. SAMEA Carfilzomib Sales Price by Application (2021-2026) & (US$/unit) Table 176. SAMEA Carfilzomib Sales Price by Application (2027-2032) & (US$/unit) Table 177. SAMEA Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Carfilzomib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Carfilzomib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Carfilzomib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 181. SAMEA Carfilzomib Sales by Country (2021-2026) & (k units) Table 182. SAMEA Carfilzomib Sales by Country (2027-2032) & (k units) Table 183. SAMEA Carfilzomib Sales Price by Country (2021-2026) & (US$/unit) Table 184. SAMEA Carfilzomib Sales Price by Country (2027-2032) & (US$/unit) Table 185. Brazil Carfilzomib Revenue (2021-2032) & (US$ Million) Table 186. Argentina Carfilzomib Revenue (2021-2032) & (US$ Million) Table 187. Chile Carfilzomib Revenue (2021-2032) & (US$ Million) Table 188. Colombia Carfilzomib Revenue (2021-2032) & (US$ Million) Table 189. Peru Carfilzomib Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Carfilzomib Revenue (2021-2032) & (US$ Million) Table 191. Israel Carfilzomib Revenue (2021-2032) & (US$ Million) Table 192. UAE Carfilzomib Revenue (2021-2032) & (US$ Million) Table 193. Turkey Carfilzomib Revenue (2021-2032) & (US$ Million) Table 194. Iran Carfilzomib Revenue (2021-2032) & (US$ Million) Table 195. Egypt Carfilzomib Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Carfilzomib Distributors List Table 199. Carfilzomib Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Carfilzomib Image Figure 2. Global Carfilzomib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carfilzomib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Injection Image Figure 5. 30mg Injection Image Figure 6. 60mg Injection Image Figure 7. Global Carfilzomib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Carfilzomib Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Center Image Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Carfilzomib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Carfilzomib Revenue (2021-2032) & (US$ Million) Figure 15. Global Carfilzomib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Carfilzomib Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Carfilzomib Revenue Market Share by Region (2021-2032) Figure 18. Global Carfilzomib Sales (2021-2032) & (k units) Figure 19. Global Carfilzomib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Carfilzomib Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Carfilzomib Sales YoY (2021-2032) & (k units) Figure 22. Europe Carfilzomib Sales YoY (2021-2032) & (k units) Figure 23. China Carfilzomib Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Carfilzomib Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Carfilzomib Sales YoY (2021-2032) & (k units) Figure 26. Global Carfilzomib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Carfilzomib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Carfilzomib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Carfilzomib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Carfilzomib Revenue Market Share by Type (2021-2032) Figure 32. Global Carfilzomib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Carfilzomib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Carfilzomib Sales Market Share by Type (2021-2032) Figure 35. Global Carfilzomib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Carfilzomib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Carfilzomib Revenue Market Share by Application (2021-2032) Figure 38. Global Carfilzomib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Carfilzomib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Carfilzomib Sales Market Share by Application (2021-2032) Figure 41. North America Carfilzomib Revenue Share by Type (2021-2032) Figure 42. North America Carfilzomib Sales Share by Type (2021-2032) Figure 43. North America Carfilzomib Revenue Share by Application (2021-2032) Figure 44. North America Carfilzomib Sales Share by Application (2021-2032) Figure 45. North America Carfilzomib Revenue Share by Country (2021-2032) Figure 46. North America Carfilzomib Sales Share by Country (2021-2032) Figure 47. Europe Carfilzomib Revenue Share by Type (2021-2032) Figure 48. Europe Carfilzomib Sales Share by Type (2021-2032) Figure 49. Europe Carfilzomib Revenue Share by Application (2021-2032) Figure 50. Europe Carfilzomib Sales Share by Application (2021-2032) Figure 51. Europe Carfilzomib Revenue Share by Country (2021-2032) Figure 52. Europe Carfilzomib Sales Share by Country (2021-2032) Figure 53. China Carfilzomib Revenue Share by Type (2021-2032) Figure 54. China Carfilzomib Sales Share by Type (2021-2032) Figure 55. China Carfilzomib Revenue Share by Application (2021-2032) Figure 56. China Carfilzomib Sales Share by Application (2021-2032) Figure 57. Asia Carfilzomib Revenue Share by Type (2021-2032) Figure 58. Asia Carfilzomib Sales Share by Type (2021-2032) Figure 59. Asia Carfilzomib Revenue Share by Application (2021-2032) Figure 60. Asia Carfilzomib Sales Share by Application (2021-2032) Figure 61. Asia Carfilzomib Revenue Share by Country (2021-2032) Figure 62. Asia Carfilzomib Sales Share by Country (2021-2032) Figure 63. SAMEA Carfilzomib Revenue Share by Type (2021-2032) Figure 64. SAMEA Carfilzomib Sales Share by Type (2021-2032) Figure 65. SAMEA Carfilzomib Revenue Share by Application (2021-2032) Figure 66. SAMEA Carfilzomib Sales Share by Application (2021-2032) Figure 67. SAMEA Carfilzomib Revenue Share by Country (2021-2032) Figure 68. SAMEA Carfilzomib Sales Share by Country (2021-2032) Figure 69. Carfilzomib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Carfilzomib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Injection
  • 30mg Injection
  • 60mg Injection
Applications
  • Drug Center
  • Hospital
  • Clinic
  • Others
Companies covered
  • Amgen
  • AstraZeneca
  • Natco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Carfilzomib Market by Type
  3. 1.2.1 Global Carfilzomib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg Injection
  5. 1.2.3 30mg Injection
  6. 1.2.4 60mg Injection
  7. 1.3 Carfilzomib Market by Application
  8. 1.3.1 Global Carfilzomib Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Center
  10. 1.3.3 Hospital
  11. 1.3.4 Clinic
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Carfilzomib Market Dynamics
  1. 2.1 Carfilzomib Industry Trends
  2. 2.2 Carfilzomib Industry Drivers
  3. 2.3 Carfilzomib Industry Opportunities and Challenges
  4. 2.4 Carfilzomib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Carfilzomib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Carfilzomib Revenue by Region
  3. 3.2.1 Global Carfilzomib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Carfilzomib Revenue by Region (2021-2026)
  5. 3.2.3 Global Carfilzomib Revenue by Region (2027-2032)
  6. 3.2.4 Global Carfilzomib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Carfilzomib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Carfilzomib Sales by Region
  9. 3.4.1 Global Carfilzomib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Carfilzomib Sales by Region (2021-2026)
  11. 3.4.3 Global Carfilzomib Sales by Region (2027-2032)
  12. 3.4.4 Global Carfilzomib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Carfilzomib Revenue by Manufacturers
  2. 4.1.1 Global Carfilzomib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Carfilzomib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Carfilzomib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Carfilzomib Sales by Manufacturers
  6. 4.2.1 Global Carfilzomib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Carfilzomib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Carfilzomib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Carfilzomib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Carfilzomib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Carfilzomib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Carfilzomib Manufacturers, Product Type & Application
  13. 4.7 Global Carfilzomib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Carfilzomib Market CR5 and HHI
  16. 4.8.2 2025 Carfilzomib Tier 1, Tier 2, and Tier 3
5 Carfilzomib Market by Type
  1. 5.1 Global Carfilzomib Revenue by Type
  2. 5.1.1 Global Carfilzomib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Carfilzomib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Carfilzomib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Carfilzomib Sales by Type
  6. 5.2.1 Global Carfilzomib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carfilzomib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Carfilzomib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Carfilzomib Price by Type
6 Carfilzomib Market by Application
  1. 6.1 Global Carfilzomib Revenue by Application
  2. 6.1.1 Global Carfilzomib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Carfilzomib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Carfilzomib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Carfilzomib Sales by Application
  6. 6.2.1 Global Carfilzomib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Carfilzomib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Carfilzomib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Carfilzomib Price by Application
7 Company Profiles
  1. 7.1 Amgen
  2. 7.1.1 Amgen Company Information
  3. 7.1.2 Amgen Business Overview
  4. 7.1.3 Amgen Carfilzomib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Carfilzomib Product Portfolio
  6. 7.1.5 Amgen Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Carfilzomib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Carfilzomib Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Natco
  14. 7.3.1 Natco Company Information
  15. 7.3.2 Natco Business Overview
  16. 7.3.3 Natco Carfilzomib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Natco Carfilzomib Product Portfolio
  18. 7.3.5 Natco Recent Developments
8 North America
  1. 8.1 North America Carfilzomib Market Size by Type
  2. 8.1.1 North America Carfilzomib Revenue by Type (2021-2032)
  3. 8.1.2 North America Carfilzomib Sales by Type (2021-2032)
  4. 8.1.3 North America Carfilzomib Price by Type (2021-2032)
  5. 8.2 North America Carfilzomib Market Size by Application
  6. 8.2.1 North America Carfilzomib Revenue by Application (2021-2032)
  7. 8.2.2 North America Carfilzomib Sales by Application (2021-2032)
  8. 8.2.3 North America Carfilzomib Price by Application (2021-2032)
  9. 8.3 North America Carfilzomib Market Size by Country
  10. 8.3.1 North America Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Carfilzomib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Carfilzomib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Carfilzomib Market Size by Type
  2. 9.1.1 Europe Carfilzomib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Carfilzomib Sales by Type (2021-2032)
  4. 9.1.3 Europe Carfilzomib Price by Type (2021-2032)
  5. 9.2 Europe Carfilzomib Market Size by Application
  6. 9.2.1 Europe Carfilzomib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Carfilzomib Sales by Application (2021-2032)
  8. 9.2.3 Europe Carfilzomib Price by Application (2021-2032)
  9. 9.3 Europe Carfilzomib Market Size by Country
  10. 9.3.1 Europe Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Carfilzomib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Carfilzomib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Carfilzomib Market Size by Type
  2. 10.1.1 China Carfilzomib Revenue by Type (2021-2032)
  3. 10.1.2 China Carfilzomib Sales by Type (2021-2032)
  4. 10.1.3 China Carfilzomib Price by Type (2021-2032)
  5. 10.2 China Carfilzomib Market Size by Application
  6. 10.2.1 China Carfilzomib Revenue by Application (2021-2032)
  7. 10.2.2 China Carfilzomib Sales by Application (2021-2032)
  8. 10.2.3 China Carfilzomib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Carfilzomib Market Size by Type
  2. 11.1.1 Asia Carfilzomib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Carfilzomib Sales by Type (2021-2032)
  4. 11.1.3 Asia Carfilzomib Price by Type (2021-2032)
  5. 11.2 Asia Carfilzomib Market Size by Application
  6. 11.2.1 Asia Carfilzomib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Carfilzomib Sales by Application (2021-2032)
  8. 11.2.3 Asia Carfilzomib Price by Application (2021-2032)
  9. 11.3 Asia Carfilzomib Market Size by Country
  10. 11.3.1 Asia Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Carfilzomib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Carfilzomib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Carfilzomib Market Size by Type
  2. 12.1.1 SAMEA Carfilzomib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Carfilzomib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Carfilzomib Price by Type (2021-2032)
  5. 12.2 SAMEA Carfilzomib Market Size by Application
  6. 12.2.1 SAMEA Carfilzomib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Carfilzomib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Carfilzomib Price by Application (2021-2032)
  9. 12.3 SAMEA Carfilzomib Market Size by Country
  10. 12.3.1 SAMEA Carfilzomib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Carfilzomib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Carfilzomib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Carfilzomib Value Chain Analysis
  2. 13.1.1 Carfilzomib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Carfilzomib Production Mode & Process
  6. 13.2 Carfilzomib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Carfilzomib Distributors
  9. 13.2.3 Carfilzomib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst